Acanthopanax senticosus polysaccharide-loaded calcium carbonate nanoparticle as an adjuvant to enhance porcine parvovirus vaccine immune responses
Medicine in Drug Discovery, ISSN: 2590-0986, Vol: 11, Page: 100094
2021
- 3Citations
- 7Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Recently, the strategy of using positively charged nanoparticles as new vaccine delivery systems has been widely investigated for enhancing the anti-infectious disease immune responses and has been found to efficiently improve the immune response through the targeting and activation of antigen-presenting cells. Acanthopanax senticosus polysaccharide (ASPS) is extracted from Acanthopanax senticosus and functions as an effective immunostimulatory drug. The present work encapsulated the ASPS immunopotentiator to the calcium carbonate (CaCO 3 ) microspheres, and adopted polyethylenimine, a cationic polymer, for coating the microspheres, finally developing the novel nanoparticle (NP) delivery system with positive charge (CaCO 3 –ASPS–PEI). As a result, our constructed CaCO 3 –ASPS–PEI remarkably up-regulated CD86 and MHCII and activated macrophages, while increasing TNF-α and IL-1β production via macrophages. Moreover, the mice immunized with porcine parvovirus (PPV) antigen adsorbed onto CaCO 3 –ASPS–PEI nanoparticles had a significant enhancement in cytokine production, the PPV-specific IgG immune response, and the hybrid Th1/Th2 immune response (dominated by Th1), relative to the remaining groups. Based on the above results, our constructed CaCO 3 –ASPS–PEI NPs with positive charge may be used as the efficient adjuvant vaccine delivery system for inducing the long-time potent immune responses.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2590098621000154; http://dx.doi.org/10.1016/j.medidd.2021.100094; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85107309893&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S2590098621000154; https://dx.doi.org/10.1016/j.medidd.2021.100094
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know